Spruce Biosciences Inc
(NAS:SPRB)
$
0.4037
0.0082 (2.07%)
Market Cap: 16.34 Mil
Enterprise Value: -40.49 Mil
PE Ratio: 0
PB Ratio: 0.32
GF Score: 32/100 Spruce Biosciences Inc at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 03:30PM GMT
Release Date Price:
$1.46
(-8.75%)
Jon Wolleben
JMP Securities LLC - Analyst
Good morning, everybody. My name is Jon Wolleben, senior analyst here at JMP. And pleased to have Spruce Biosciences joining us for a talk. We've got CEO -- recently minted CEO, Javier Szwarcberg. Close?
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
Close enough.
Jon Wolleben
JMP Securities LLC - Analyst
Close enough. Well, thank you for coming, Javier.
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
My pleasure.
Questions & Answers
Jon Wolleben
JMP Securities LLC - Analyst
And for those who aren't as familiar with Spruce, this is a company we've been digging into for a little bit of time now. But tell us what you guys are working on.
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
So, we're working on a compound that inhibits the CRF1 receptor. It's an antagonist of receptor targeting two disease states, one is CAH,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot